Autoplaque vs qXR-CTR
AI Verdict
Choose Autoplaque if…
Choose Autoplaque if your clinical workflow requires detailed, quantitative analysis of coronary artery plaque and luminal stenoses from CT angiography images. This tool is ideal for precise heart attack risk prediction and guiding treatment strategies based on comprehensive characterization of coronary anatomy and pathology.
View Autoplaque →Choose qXR-CTR if…
Choose qXR-CTR if you need an automated, rapid assessment of heart size from standard chest X-ray images. This solution is best suited for initial screening to identify potential cardiomegaly and assess heart failure risk efficiently in high-volume environments.
View qXR-CTR →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Autoplaque | qXR-CTR |
|---|---|---|
| Pricing | Unknown | Contact for pricing |
| Deployment | Workstation-based post-processing application, runs on Windows or Mac OS. | Cloud, on-premise, hybrid |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
qXR-CTRqXR-CTR offers superior usability due to its flexible deployment options (cloud, on-premise, hybrid) and broader platform support (Web, iOS, Android, Windows, macOS, Linux). It emphasizes seamless integration into existing radiology workflows, pre-read assistance, and multilingual support, making it accessible and efficient for a wider range of clinical settings and users.
Clinical Value
AutoplaqueAutoplaque provides a more in-depth and quantitative analysis of coronary plaques and luminal stenoses from CT angiography, including the characterization of plaque subtypes directly linked to heart attack risk prediction and treatment guidance. This offers more specific and actionable diagnostic insights for advanced cardiovascular disease management compared to qXR-CTR's automated cardiothoracic ratio measurement, which serves as a screening indicator for potential heart failure.
Pricing & Value
qXR-CTRWhile both tools have undisclosed pricing, qXR-CTR provides more transparency by stating its pricing model is subscription-based and dependent on the number of analyses or installations. This offers some insight into potential cost structures, whereas Autoplaque provides no pricing details whatsoever.
Enterprise Readiness
qXR-CTRqXR-CTR demonstrates superior enterprise readiness with explicit HIPAA compliance and BAA availability, flexible cloud, on-premise, and hybrid deployment options, and a wide array of integration partners and security features. Its commercial focus as a dedicated AI company with a global presence and numerous paying customers further solidifies its enterprise capabilities.
Innovation
AutoplaqueAutoplaque demonstrates a higher degree of innovation by performing sophisticated quantitative analysis and characterization of various coronary plaque components and stenoses from complex 3D CT angiography images, directly aiding in heart attack risk prediction. This involves more advanced AI for detailed anatomical and pathological assessment compared to the automated 2D measurement of cardiothoracic ratio by qXR-CTR.
Support & Docs
qXR-CTRqXR-CTR clearly outlines a comprehensive set of support channels including email, phone, chat, ticketing, and 24x7 availability, along with various training options like documentation, webinars, live online, onsite, and certification. This level of explicit and extensive support and documentation is not specified for Autoplaque.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Autoplaque | qXR-CTR |
|---|---|---|
| Name | Autoplaque | qXR-CTR |
| Company | Cedars-Sinai Medical Center: AIM | Qure.ai Technologies |
| Description | AI-powered software for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance. | AI-powered software that automates the measurement of the cardiothoracic ratio (CTR) from chest X-ray images, aiding in the assessment of heart size and potential heart failure risk. |
| Key Analysis/Measurements | Quantitative analysis of atherosclerotic plaque, detection and characterization of coronary artery plaque, measurement of luminal stenoses, automated vessel, plaque, and lumen segmentation. | Automated measurement of the cardiothoracic ratio (CTR). |
| Target Imaging Modality | CT angiography images | Chest X-ray images |
Videos
Demos, reviews, and walkthroughs featuring Autoplaque and qXR-CTR.